nach oben

Virchows Archiv

Erschienen in:

27.10.2020 | Review and Perspectives

Vaping-related lung injury

verfasst von: Maxwell L. Smith, Michael B. Gotway, Laura E. Crotty Alexander, Lida P. Hariri

Erschienen in: Virchows Archiv | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

The use of electronic nicotine delivery systems has increased in popularity dramatically over the past decade. Although lung diseases caused by vaping have been reported since the modern invention of the electronic cigarette, in the summer of 2019, patients began to present to health care centers at epidemic levels with an acute respiratory illness relating to vaping, which the Center for Disease Control termed E-cigarette or vaping product use-associated lung injury (EVALI). This review discusses electronic nicotine delivery systems as well as the etiology, clinical presentation, imaging findings, pathologic features, treatment, and long-term consequences of EVALI. We conclude with the practical impact EVALI has had on the practice of pathology.

Crotty Alexander LE et al (2015) Electronic cigarettes: the new face of nicotine delivery and addiction. J Thorac Dis 7(8):E248–E251PubMedPubMedCentral

Bozier J, et al.,( 2020) The evolving landscape of electronic cigarettes: a systematic review of recent evidence. Chest

Huang J et al (2019) Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market. Tob Control 28(2):146–151CrossRef

Arrazola RA et al (2015) Tobacco use among middle and high school students - United States, 2011-2014. MMWR Morb Mortal Wkly Rep 64(14):381–385PubMedPubMedCentral

Leventhal AM et al (2019) Flavored E-cigarette use and progression of vaping in adolescents. Pediatrics 144(5):e20190789CrossRef

Chaffee BW, Watkins SL, Glantz SA (2018) Electronic cigarette use and progression from experimentation to established smoking. Pediatrics 141(4):e20173594CrossRef

Chatham-Stephens K et al (2019) Characteristics of hospitalized and nonhospitalized patients in a nationwide outbreak of E-cigarette, or vaping, product use-associated lung injury - United States, November 2019. MMWR Morb Mortal Wkly Rep 68(46):1076–1080CrossRef

Blount, B.C., et al., Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI N Engl J Med, 2020. 382(8): p. 697–705

Downs, D. Vape cart additive makers pull products as others go dark. 2019 [cited 2020 July 10th, 2020]; Available from: https://www.leafly.com/news/health/some-vape-cart-additive-makers-pull-products-others-go-dark. Accessed 19 Aug 2020

10.

Wu D, O'Shea DF (2020) Potential for release of pulmonary toxic ketene from vaping pyrolysis of vitamin E acetate. Proc Natl Acad Sci U S A 117(12):6349–6355CrossRef

11.

Bhat TA et al (2020) An animal model of inhaled vitamin E acetate and EVALI-like lung injury. N Engl J Med

12.

Alexander LEC, Bellinghausen AL, Eakin MN (2020) What are the mechanisms underlying vaping-induced lung injury? J Clin Invest 130(6):2754–2756CrossRef

13.

Crotty Alexander LE, et al., (2020) NIH workshop report: E-cigarette or vaping product use associated lung injury (EVALI): developing a research agenda. Am J Respir Crit Care Med

14.

Kligerman S et al (2020) Radiologic, pathologic, clinical, and physiologic findings of electronic cigarette or vaping product use-associated lung injury (EVALI): evolving knowledge and remaining questions. Radiology 294(3):491–505CrossRef

15.

Henry TS, Kanne JP, Kligerman SJ (2019) Imaging of vaping-associated lung disease. N Engl J Med 381(15):1486–1487CrossRef

16.

Henry TS et al (2020) Imaging findings of vaping-associated lung injury. AJR Am J Roentgenol 214(3):498–505CrossRef

17.

Layden JE et al (2020) Pulmonary illness related to E-cigarette use in Illinois and Wisconsin - final report. N Engl J Med 382(10):903–916CrossRef

18.

Viswam D et al (2018) Respiratory failure caused by lipoid pneumonia from vaping e-cigarettes. BMJ Case Rep:2018

19.

Saqi A et al (2020) E-cigarette or vaping product use-associated lung injury: what is the role of cytologic assessment? Cancer Cytopathol 128(6):371–380CrossRef

20.

McCauley L, Markin C, Hosmer D (2012) An unexpected consequence of electronic cigarette use. Chest 141(4):1110–1113CrossRef

21.

Davidson K et al (2019) Outbreak of electronic-cigarette-associated acute lipoid pneumonia - North Carolina, July-august 2019. MMWR Morb Mortal Wkly Rep 68(36):784–786CrossRef

22.

Maddock SD et al (2019) Pulmonary lipid-laden macrophages and vaping. N Engl J Med 381(15):1488–1489CrossRef

23.

Basset-Leobon C et al (2010) Cut-off values and significance of Oil Red O-positive cells in bronchoalveolar lavage fluid. Cytopathology 21(4):245–250CrossRef

24.

Corwin RW, Irwin RS (1985) The lipid-laden alveolar macrophage as a marker of aspiration in parenchymal lung disease. Am Rev Respir Dis 132(3):576–581PubMed

25.

Pambuccian SE (2020) Testing for lipid-laden macrophages in bronchoalveolar lavage fluid to diagnose vaping-associated pulmonary injury. Are we there yet? J Am Soc Cytopathol 9(1):1–8CrossRef

26.

Butt YM et al (2019) Pathology of vaping-associated lung injury. N Engl J Med 381(18):1780–1781CrossRef

27.

Mukhopadhyay S et al (2020) Lung biopsy findings in severe pulmonary illness associated with E-cigarette use (vaping). Am J Clin Pathol 153(1):30–39PubMed

28.

Beasley MB (2010) The pathologist’s approach to acute lung injury. Arch Pathol Lab Med 134(5):719–727CrossRef

29.

Fels Elliott DR et al (2019) Giant cell interstitial pneumonia secondary to cobalt exposure from e-cigarette use. Eur Respir J 54(6)

30.

Kalininskiy A et al (2019) E-cigarette, or vaping, product use associated lung injury (EVALI): case series and diagnostic approach. Lancet Respir Med 7(12):1017–1026CrossRef

31.

Alexander LEC, Perez MF (2019) Identifying, tracking, and treating lung injury associated with e-cigarettes or vaping. Lancet

32.

Centers for Disease Control and Prevention (CDC). Outbreak of lung injury associated with the use of E-cigarette, or vaping, products.; Available from: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html#latest-information. Accessed 19 Aug 2020

33.

Desai SR et al (1999) Acute respiratory distress syndrome: CT abnormalities at long-term follow-up. Radiology 210(1):29–35CrossRef

34.

Sheard S, Rao P, Devaraj A (2012) Imaging of acute respiratory distress syndrome. Respir Care 57(4):607–612CrossRef

35.

Carroll BJ et al (2020) Impaired lung function following e-cigarette or vaping product use associated lung injury in the first cohort of hospitalized adolescents. Pediatr Pulmonol 55(7):1712–1718CrossRef

36.

Corcoran A, Carl JC, Rezaee F (2020) The importance of anti-vaping vigilance-EVALI in seven adolescent pediatric patients in Northeast Ohio. Pediatr Pulmonol 55(7):1719–1724CrossRef

37.

Centers for Disease Control and Prevention (CDC). Health effects of cigarette smoking. . August 24, 2020]; Available from: https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/index.htm. Accessed 19 Aug 2020

38.

Cecchini, M.J., et al., (2020) E-cigarette or vaping product use-associated lung injury: a review for pathologists. Arch Pathol Lab Med

39.

Callahan, S.J., et al., (2020) Diagnosing EVALI in the time of COVID-19. Chest

Titel: Vaping-related lung injury
verfasst von: Maxwell L. Smith
Michael B. Gotway
Laura E. Crotty Alexander
Lida P. Hariri
Publikationsdatum: 27.10.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: Virchows Archiv / Ausgabe 1/2021
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-020-02943-0

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Vaping-related lung injury

Abstract

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas

Morphologic and molecular classification of lung neuroendocrine neoplasms

Recent advances and conceptual changes in the classification of neuroendocrine tumors of the thymus

Challenges in lung and thoracic pathology

Molecular approach to the classification of chronic fibrosing lung disease—there and back again

Common and rare carcinomas of the thymus

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren